Similar articles

• Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs.

  Lauersen NH, Graves ZR. Lauersen NH, et al. J Reprod Med. 1984 Feb;29(2):133-5. J Reprod Med. 1984. PMID: 6708030
• [Preoperative dilatation of the cervix uteri by vaginal application of 9-deoxo-16, 16-dimethyl-9-methylene PGE2 in pregnancy interruption during the 1st trimester. Double-blind clinical study].

  Friedli A, De Grandi P. Friedli A, et al. J Gynecol Obstet Biol Reprod (Paris). 1986;15(2):215-21. J Gynecol Obstet Biol Reprod (Paris). 1986. PMID: 3522723 Clinical Trial. French.
• Prostaglandin vaginal suppositories in non pregnant women requiring cervical dilatation prior to hysteroscopy.

  Hald F, Kristoffersen SE, Gregersen E. Hald F, et al. Acta Obstet Gynecol Scand. 1988;67(3):219-22. doi: 10.3109/00016348809004206. Acta Obstet Gynecol Scand. 1988. PMID: 3051874 Clinical Trial.
• Effects of prostaglandin E2 analogue suppository on blood loss in suction abortion.

  Sidhu MS, Kent DR. Sidhu MS, et al. Obstet Gynecol. 1984 Jul;64(1):128-30. Obstet Gynecol. 1984. PMID: 6738937 Clinical Trial.
• Study of 16,16'-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal suppository for cervical dilatation in premenopausal and postmenopausal women.

  Rabe T, Willinger G, Kiesel L, Runnebaum B, Kubili F, Mösche R, Nobakht N. Rabe T, et al. Adv Contracept. 1985 Mar;1(1):91-102. doi: 10.1007/BF01849148. Adv Contracept. 1985. PMID: 3916041 Clinical Trial.